Letter to the Shareholders – June 2018
We are very pleased to announce that we late yesterday received the permission from MHRA (UK health authorities) to start the CE mark human trial…
We are very pleased to announce that we late yesterday received the permission from MHRA (UK health authorities) to start the CE mark human trial…